At the conclusion of this presentation, the audience should be better able to:
✔️ Discuss current evidence surrounding clinical trials for COVID-19 therapeutics.
✔️ Describe the FDA's Coronavirus Treatment Acceleration Program (CTAP) when determining new treatments for COVID that are deemed safe and effective.
🗣️ SPEAKERS:
🔸 Aneesh K. Mehta, MD
🔸 Andre Kalil, MD, MPH, FACP, FIDSA, FCCM
🔸 Noreen A. Hynes, MD, MPH
👩💻 MODERATOR:
Trish Tennill, Associate Director of Nursing, Special Pathogens Program, NYC Health + Hospitals/Bellevue
➡️ Get educational credit for this webinar through: [ Ссылка ]
